MYLAN AUSTRALIA — Dexamethasone Importer Profile
Pharmaceutical Importer · #14 buyer for Dexamethasone · $1.8M import value · 53 shipments · AUSTRALIA · DGFT Verified
MYLAN AUSTRALIA is the #14 importer of Dexamethasone from India with $1.8M in import value and 53 verified shipments. MYLAN AUSTRALIA holds a 1.0% market share in Dexamethasone imports based in AUSTRALIA. The company sources from 1 verified supplier across 22 formulations shipped to 1 country. Overall, MYLAN AUSTRALIA imports 3 pharmaceutical products worth $6.3M across 3 therapeutic categories.
MYLAN AUSTRALIA — Dexamethasone Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Dexamethasone to MYLAN AUSTRALIA?
Verified from 53 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MYLAN LABORATORIES LIMITED | $1.8M | 53 | 100.0% |
MYLAN AUSTRALIA sources Dexamethasone from 1 verified Indian supplier based on 53 customs records. The primary supplier is MYLAN LABORATORIES LIMITED accounting for 100.0% of imports.
How Does MYLAN AUSTRALIA Compare to Nearest Dexamethasone Importers?
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | EUGIA US LLC | UNITED STATES | $2.3M | 46 | $50.0K |
| 13 | MYLAN INSTITUTIONAL INC 2898 | UNITED STATES | $1.9M | 39 | $50.0K |
| 14 | MYLAN AUSTRALIA ★ | AUSTRALIA | $1.9M | 53 | $35.4K |
| 11 | LLC SENTISS RUS | RUSSIA | $1.4M | 27 | $50.0K |
| 4 | SUN PHARMACEUTICAL INDUSTRIES,INC. | UNITED STATES | $1.3M | 26 | $50.0K |
MYLAN AUSTRALIA ranks #14 among 2,257 Dexamethasone importers from India. Average shipment value of $35.4K compared to the market average of $7.9K. The closest competitors by value are EUGIA US LLC and MYLAN INSTITUTIONAL INC 2898.
Where Does MYLAN AUSTRALIA Import Dexamethasone To?
Destination countries from 53 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $1.8M | 53 | 100.0% |
MYLAN AUSTRALIA imports Dexamethasone to 1 country. The primary destination is AUSTRALIA receiving 100.0% of shipments worth $1.8M.
What Dexamethasone Formulations Does MYLAN AUSTRALIA Import?
| Formulation | Value | Shipments |
|---|---|---|
| DEXAMETHASONE MYLAN INJ 8MG/2ML 5S MYL A | $852.8K | 18 |
| DEXAMETHASONE VIATRIS INJ 8MG/2ML-5S-AUS | $250.0K | 5 |
| DEXAMETHASONE VIATRIS INJ 8MG/2ML-5S AUS | $150.0K | 3 |
| DEXAMETHASONE VIATRIS INJ 8MG/2ML 5S AUS | $100.0K | 2 |
| DEXAMETHASONE VIATRIS INJ 4MG/1ML-5S-AUS/ BATCH NO:7608895 TAXABLE VALUE:2272425.33 | $51.5K | 2 |
| DEXAMETHASONE VIATRIS INJ 4MG/1ML-5S-AUS/BATCH NO:7608882/ TAXABLE VALUE:2251519.19 | $51.0K | 2 |
| DEXAMETHASONE VIATRIS INJ 4MG/1ML-5S-AUS/ BATCH NO: 7608896 / TAXABLE VALUE :2242724.19 | $50.8K | 2 |
| DEXAMETHASONE VIATRIS INJ 8MG/2ML 5S AUS7608790 TAX 4456024.67 | $50.0K | 1 |
| DEXAMETHASONE VIATRIS INJ 8MG/2ML 5S AUS7608778 TAX VAL 4470399.79 | $50.0K | 1 |
| DEXAMETHASONE VIATRIS INJ 4MG/1ML-5S-AUSBATCH NO:7609040 TAXABLE VALUE:2268770.29NOS | $26.6K | 1 |
MYLAN AUSTRALIA imports 22 distinct Dexamethasone formulations from India. The top formulation is DEXAMETHASONE MYLAN INJ 8MG/2ML 5S MYL A with 18 shipments worth $852.8K.
Regulatory Requirements: Importing Dexamethasone into Australia
What MYLAN AUSTRALIA and other importers must comply with to import Dexamethasone from India
Regulatory Authority
Therapeutic Goods Administration (TGA)
Approval Process for Generic Dexamethasone
Application for registration on the Australian Register of Therapeutic Goods (ARTG). Generic pathway requires bioequivalence and quality data per TGA guidelines.
Typical timeline: 10–14 months
GMP Requirements
TGA GMP clearance; PIC/S-aligned inspection of overseas manufacturing facilities
Import Licence & Documentation
TGA manufacturing licence or sponsor licence for import; GMP clearance for each manufacturing site
Labeling & Packaging
Australian-specific labeling per TGO 91/92; English language; AUST R number
Note: TGA participates in PIC/S mutual recognition — PIC/S GMP certificate from India may expedite clearance.
Regulatory information is provided for general reference based on publicly available TGA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with TGA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Dexamethasone from India and How Much Does MYLAN AUSTRALIA Import?
India exported $17.9M worth of Dexamethasone through 8,777 shipments from 808 suppliers to 176 countries, serving 2,257 buyers globally. MYLAN AUSTRALIA imports $1.8M of this total, accounting for 1.0% of India's Dexamethasone exports with 53 shipments from AUSTRALIA. This is verified from 53 customs shipment records covering 22 distinct formulations.
What Is the Average Order Value for MYLAN AUSTRALIA's Dexamethasone Imports?
MYLAN AUSTRALIA's average Dexamethasone order value is $34.5K per consignment, based on 53 shipments totaling $1.8M. MYLAN AUSTRALIA is based in AUSTRALIA and ranks #14 among all Dexamethasone importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Dexamethasone to MYLAN AUSTRALIA?
MYLAN AUSTRALIA sources Dexamethasone from 1 verified Indian supplier: MYLAN LABORATORIES LIMITED ($1.8M, 100.0%). This is based on 53 customs records.
How Does MYLAN AUSTRALIA Compare to Other Dexamethasone Importers?
MYLAN AUSTRALIA ranks #14 among 2,257 Dexamethasone importers from India with a 1.0% market share. The top 3 importers are RX CROSSROADS 3PL LLC ($3.2M), EUGIA US LLC ($2.3M), MYLAN INSTITUTIONAL INC 2898 ($1.9M). MYLAN AUSTRALIA processed 53 shipments from AUSTRALIA.
About MYLAN AUSTRALIA
MYLAN AUSTRALIA imports 3 products worth $6.3M. Beyond Dexamethasone, top products include Vancomycin, Fluticasone. View the complete MYLAN AUSTRALIA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dexamethasone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Dexamethasone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MYLAN AUSTRALIA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MYLAN AUSTRALIA's capped import value divided by total capped export value for Dexamethasone across all Indian exporters.
- 5.Verified Records: This page is backed by 53 individual customs records matching MYLAN AUSTRALIA importing Dexamethasone, covering 22 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 176+ countries, 2,257+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Dexamethasone Import Data for MYLAN AUSTRALIA
Access order-level details, pricing data, supplier connections, and competitive analysis for MYLAN AUSTRALIA's Dexamethasone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MYLAN AUSTRALIA
Full Company Profile →
3 products · $6.3M total trade · 3 categories
MYLAN AUSTRALIA × Dexamethasone
Verified from customs records
Company Overview
Top Products by MYLAN AUSTRALIA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MYLAN AUSTRALIA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dexamethasone. For current order-level data, contact TransData Nexus.